SOLVE first Annual Meeting

🚀 Launch of the SOLVE first Annual Meeting!

🔬 EUCLID-MART is pleased to take part in the Annual Meeting of the SOLVE clinical trial – Sustainable Covid-19 Vaccination for Long-term Vaccine Immunity and Effectiveness, taking place today and tomorrow in Madrid and hosted by Mariano Esteban (CSIC).

This project funded by Horizon Europe is coordinated by Inserm   – scientific coordinator Yves Lévy. It aims to decode the mechanisms behind long-term immunity by directly comparing vaccine platforms and exploring new vaccine concepts against Covid-19.

This key event brings together leading researchers and partners across Europe to advance long-term strategies for COVID-19 vaccination. EUCLID-MART is committed to supporting robust, collaborative clinical research that drives meaningful public health outcomes.

As lead of the “Clinical Trial” Work Package, Linda Wittkop, for EUCLID-MART, is actively involved in conducting a trial, sponsored by ANRS MIE, on small cohorts of volunteers, bringing its full CTU expertise to the table.

Partners include Inserm VRI, SISTM, CEA, CHUV, CSIC, EVF, KUL, UNIMI, UPEC, and UQTM.

We are proud to contribute to this collaborative effort, shaping the future of COVID-19 vaccination. Lunch of the SOLVE first Annual Meeting! 💉🌍